These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

292 related items for PubMed ID: 11681260

  • 1. [Prostate cancer].
    Uchida K, Akaza H.
    Gan To Kagaku Ryoho; 2001 Oct; 28(10):1469-74. PubMed ID: 11681260
    [Abstract] [Full Text] [Related]

  • 2. Prostate specific antigen density for discriminating prostate cancer from benign prostatic hyperplasia in the gray zone of prostate-specific antigen.
    Uno H, Koide T, Kuriyama M, Ban Y, Deguchi T, Kawada Y.
    Hinyokika Kiyo; 1999 Jul; 45(7):457-61. PubMed ID: 10466060
    [Abstract] [Full Text] [Related]

  • 3. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, Saito I.
    Hinyokika Kiyo; 2007 Jul; 53(7):459-65. PubMed ID: 17702178
    [Abstract] [Full Text] [Related]

  • 4. PSA density and PSA transition zone density in the diagnosis of prostate cancer in PSA gray zone cases.
    Aksoy Y, Oral A, Aksoy H, Demirel A, Akcay F.
    Ann Clin Lab Sci; 2003 Jul; 33(3):320-3. PubMed ID: 12956448
    [Abstract] [Full Text] [Related]

  • 5. [Value of prostate specific antigen in early diagnosis of prostatic cancer].
    Xiao LP, Bi XJ, Li YN, Chen XQ, Zhang XF, Yu XP, Liu G, Yang MC, Song Z.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):107-8, 112. PubMed ID: 17259162
    [Abstract] [Full Text] [Related]

  • 6. [Combined use of PSA density and free to total PSA ratio for cancer detection from patients with PSA elevations].
    Kawai M, Okajima K, Kobayashi K, Moriyama M.
    Hinyokika Kiyo; 2006 Feb; 52(2):113-7. PubMed ID: 16541764
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of serum markers for prostate cancer.
    Stenman UH, Abrahamsson PA, Aus G, Lilja H, Bangma C, Hamdy FC, Boccon-Gibod L, Ekman P.
    Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
    [Abstract] [Full Text] [Related]

  • 8. Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.
    Suzuki H, Akakura K, Igarashi T, Ueda T, Ito H, Watanabe M, Nomura F, Ochiai T, Shimada H.
    J Urol; 2004 Jan; 171(1):182-6. PubMed ID: 14665872
    [Abstract] [Full Text] [Related]

  • 9. Advances in the application of prostate-specific antigen in the detection of early-stage prostate cancer.
    Kamoi K, Babaian RJ.
    Semin Oncol; 1999 Apr; 26(2):140-9. PubMed ID: 10597725
    [Abstract] [Full Text] [Related]

  • 10. [Prostate specific antigen: a role of PSA in the diagnosis of prostate cancer].
    Nutahara K, Higashihara E.
    Rinsho Byori; 2001 Oct; 49(10):963-6. PubMed ID: 11769472
    [Abstract] [Full Text] [Related]

  • 11. The potential role of prebiopsy magnetic resonance imaging combined with prostate-specific antigen density in the detection of prostate cancer.
    Kubota Y, Kamei S, Nakano M, Ehara H, Deguchi T, Tanaka O.
    Int J Urol; 2008 Apr; 15(4):322-6; discussion 327. PubMed ID: 18380820
    [Abstract] [Full Text] [Related]

  • 12. [The usefulness of percentage of free prostate specific antigen/prostate specific antigen density in the diagnosis of prostate cancer].
    Han G, Gao JP, Cao XL, Hong BF, Tang J.
    Zhonghua Wai Ke Za Zhi; 2006 Mar 15; 44(6):379-81. PubMed ID: 16638346
    [Abstract] [Full Text] [Related]

  • 13. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
    Kobayashi T, Kawahara T, Nishizawa K, Ogura K, Mitsumori K, Ide Y.
    BJU Int; 2005 Jun 15; 95(9):1245-8. PubMed ID: 15892809
    [Abstract] [Full Text] [Related]

  • 14. Prospective evaluation of prostate cancer detection by prostate specific antigen related parameters: comparison in serum and plasma samples.
    Egawa S, Suyama K, Matsumoto K, Kuwao S, Baba S.
    J Urol; 2002 Jan 15; 167(1):97-102. PubMed ID: 11743284
    [Abstract] [Full Text] [Related]

  • 15. The significance of prostate-specific antigen alpha-1-antichymotrypsin complex and its indices for the detection of prostate cancer.
    Yamanaka K, Yamada Y, Kobayashi Y, Ueno K, Takechi Y, Hasegawa E, Chikahira Y.
    Hinyokika Kiyo; 2003 Jan 15; 49(1):5-10. PubMed ID: 12629773
    [Abstract] [Full Text] [Related]

  • 16. Value of prostate-specific antigen and prostate-specific antigen density in detection of prostate cancer in an Iranian population of men.
    Ghafoori M, Varedi P, Hosseini SJ, Asgari M, Shakiba M.
    Urol J; 2009 Jan 15; 6(3):182-8. PubMed ID: 19711272
    [Abstract] [Full Text] [Related]

  • 17. [Prostate-specific antigen].
    Eide IA, Angelsen A.
    Tidsskr Nor Laegeforen; 2000 Sep 10; 120(21):2528-31. PubMed ID: 11070990
    [Abstract] [Full Text] [Related]

  • 18. Inverse association between histologic inflammation in needle biopsy specimens and prostate cancer in men with serum PSA of 10-50 ng/mL.
    Terakawa T, Miyake H, Kanomata N, Kumano M, Takenaka A, Fujisawao M.
    Urology; 2008 Dec 10; 72(6):1194-7. PubMed ID: 18829081
    [Abstract] [Full Text] [Related]

  • 19. Prostate-specific antigen density adjusted for the transition zone for staging clinically localized prostate cancer in Japanese patients with intermediate serum prostate-specific antigen levels.
    Furuya Y, Ohta S, Sato N, Kotake T, Sugano I, Nagao K, Masai M.
    Anticancer Res; 2001 Dec 10; 21(2B):1317-20. PubMed ID: 11396206
    [Abstract] [Full Text] [Related]

  • 20. [PSAD and PSA-AD in the early diagnosis of cancer of the prostate].
    Allepuz Losa C, Sanz JI, Carela J, Benejam J, García-Miralles R, Rioja Sanz LA.
    Actas Urol Esp; 1997 Oct 10; 21(9):843-51. PubMed ID: 9471867
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.